Ann L Jennerich1, Joseph B Pryor2, Travis Y Hee Wai3, Siddhartha G Kapnadak3, Moira L Aitken3, Christopher H Goss4, Kathleen J Ramos3. 1. Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington, 325 Ninth Avenue, Box 359762, Seattle, WA 98104, United States. Electronic address: along11@uw.edu. 2. Department of General Internal Medicine, University of Washington, Seattle, WA, United States. 3. Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington, 325 Ninth Avenue, Box 359762, Seattle, WA 98104, United States. 4. Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington, 325 Ninth Avenue, Box 359762, Seattle, WA 98104, United States; Department of Pediatrics, Division of Pulmonary and Sleep Medicine, University of Washington, Seattle, WA, United States.
Abstract
RATIONALE: Low body mass index (BMI) may influence lung transplant decisions for patients with advanced cystic fibrosis (CF) lung disease. OBJECTIVE: Determine whether patients with advanced CF lung disease and BMI ≤17 kg/m2 are less likely to be listed for lung transplant or have a higher risk of death without listing compared to those with higher BMI. METHODS: Using merged United Network for Organ Sharing and CF Foundation Patient Registries, we identified adults with onset of advanced lung disease (FEV1 ≤ 40% predicted) between May-2005 and December-2016. We analyzed survival using competing risks regression with cause-specific risks of listing for lung transplant and death without listing. BMI ≤ 17 kg/m2 was our predictor. MEASUREMENTS AND MAIN RESULTS: Among 5,121 CF patients with advanced lung disease, 23% were listed for lung transplant (n = 1,201), 23% died without listing (n = 1,190), and 44% were alive without listing (n = 2,730) as of December-2016. Patients with BMI ≤ 17 kg/m2 were less likely to be listed for transplant (HR 0.69; 95% CI 0.57, 0.83) and more likely to die without listing (HR 1.63; 95% CI 1.41, 1.88). We identified important regional variations in the likelihood of referral and listing, based on BMI. CONCLUSIONS: Patients with advanced CF lung disease and BMI ≤ 17 kg/m2 are less likely to be listed for lung transplant and have a higher risk of dying without listing, compared to those with higher BMI. Regional differences suggest access to transplant for malnourished CF patients may be limited by location.
RATIONALE: Low body mass index (BMI) may influence lung transplant decisions for patients with advanced cystic fibrosis (CF) lung disease. OBJECTIVE: Determine whether patients with advanced CF lung disease and BMI ≤17 kg/m2 are less likely to be listed for lung transplant or have a higher risk of death without listing compared to those with higher BMI. METHODS: Using merged United Network for Organ Sharing and CF Foundation Patient Registries, we identified adults with onset of advanced lung disease (FEV1 ≤ 40% predicted) between May-2005 and December-2016. We analyzed survival using competing risks regression with cause-specific risks of listing for lung transplant and death without listing. BMI ≤ 17 kg/m2 was our predictor. MEASUREMENTS AND MAIN RESULTS: Among 5,121 CF patients with advanced lung disease, 23% were listed for lung transplant (n = 1,201), 23% died without listing (n = 1,190), and 44% were alive without listing (n = 2,730) as of December-2016. Patients with BMI ≤ 17 kg/m2 were less likely to be listed for transplant (HR 0.69; 95% CI 0.57, 0.83) and more likely to die without listing (HR 1.63; 95% CI 1.41, 1.88). We identified important regional variations in the likelihood of referral and listing, based on BMI. CONCLUSIONS: Patients with advanced CF lung disease and BMI ≤ 17 kg/m2 are less likely to be listed for lung transplant and have a higher risk of dying without listing, compared to those with higher BMI. Regional differences suggest access to transplant for malnourished CF patients may be limited by location.
Authors: Gabriela Cristofoli Barni; Gabriele Carra Forte; Luis Felipe Forgiarini; Claudine Lacerda de Oliveira Abrahão; Paulo de Tarso Roth Dalcin Journal: J Bras Pneumol Date: 2017-07-31 Impact factor: 2.624
Authors: C Schwebel; I Pin; D Barnoud; G Devouassoux; P Y Brichon; P Chaffanjon; O Chavanon; C Sessa; D Blin; M Guignier; X Leverve; C Pison Journal: Eur Respir J Date: 2000-12 Impact factor: 16.671
Authors: Daniel A Culver; Peter J Mazzone; Farah Khandwala; Holli C Blazey; Malcolm M Decamp; Jeffrey T Chapman Journal: J Heart Lung Transplant Date: 2005-02 Impact factor: 10.247
Authors: Bradley S Quon; Kevin Psoter; Nicole Mayer-Hamblett; Moira L Aitken; Christopher I Li; Christopher H Goss Journal: Am J Respir Crit Care Med Date: 2012-09-13 Impact factor: 21.405
Authors: Anne L Stephenson; Kathleen J Ramos; Jenna Sykes; Xiayi Ma; Sanja Stanojevic; Bradley S Quon; Bruce C Marshall; Kristofer Petren; Joshua S Ostrenga; Aliza K Fink; Albert Faro; Alexander Elbert; Cecilia Chaparro; Christopher H Goss Journal: J Heart Lung Transplant Date: 2020-12-07 Impact factor: 10.247